{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:39:39Z","timestamp":1791092379992,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:p>Circulating angiotensin II (Ang II) activates a central aldosterone\u2013mineralocorticoid receptor neuromodulatory pathway, which mediates most of the Ang II\u2013induced hypertension. This study examined whether specific central infusion of Ang II also activates this central aldosterone\u2013mineralocorticoid receptor pathway. Intracerebroventricular infusion of Ang II at 1.0, 2.5, and 12.5 ng\/min for 2 weeks caused dose-related increases in water intake, Ang II concentration in the cerebrospinal fluid, and blood pressure. Intracerebroventricular Ang II, at 2.5 and 12.5 ng\/min, increased hypothalamic aldosterone and corticosterone, as well as plasma aldosterone and corticosterone without affecting plasma Ang II levels. Intracerebroventricular infusion of the aldosterone synthase inhibitor FAD286\u2014but not the mineralocorticoid receptor blocker eplerenone\u2014inhibited by \u224860% the Ang II\u2013induced increase in hypothalamic aldosterone. Both blockers attenuated by \u224850% the increase in plasma aldosterone and corticosterone with only minimal effects on hypothalamic corticosterone. By telemetry, intracerebroventricular infusion of Ang II maximally increased blood pressure within the first day with no further increase over the next 2 weeks. Intracerebroventricular infusion of FAD286 or eplerenone did not affect the initial pressor responses but similarly prevented 60% to 70% of the chronic pressor responses to intracerebroventricular infusion of Ang II. These results indicate distinctly different patterns of blood pressure increase by circulating versus central Ang II and support the involvement of a brain aldosterone\u2013mineralocorticoid receptor\u2013activated neuromodulatory pathway in the chronic hypertension caused by both circulating and central Ang II.<\/jats:p>","DOI":"10.1161\/hypertensionaha.113.01557","type":"journal-article","created":{"date-parts":[[2013,7,15]],"date-time":"2013-07-15T21:39:06Z","timestamp":1373924346000},"page":"564-571","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":24,"title":["Role of Brain Corticosterone and Aldosterone in Central Angiotensin II\u2013Induced Hypertension"],"prefix":"10.1161","volume":"62","author":[{"given":"Bing S.","family":"Huang","sequence":"first","affiliation":[{"name":"From the Hypertension Unit, University of Ottawa Heart Institute, Ottawa, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roselyn A.","family":"White","sequence":"additional","affiliation":[{"name":"From the Hypertension Unit, University of Ottawa Heart Institute, Ottawa, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monir","family":"Ahmad","sequence":"additional","affiliation":[{"name":"From the Hypertension Unit, University of Ottawa Heart Institute, Ottawa, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans H.H.","family":"Leenen","sequence":"additional","affiliation":[{"name":"From the Hypertension Unit, University of Ottawa Heart Institute, Ottawa, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1997.tb01789.x"},{"issue":"1","key":"e_1_3_4_3_2","first-page":"R200","article-title":"Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency.","volume":"271","author":"Li Q","year":"1996","unstructured":"Li Q, Dale WE, Hasser EM, Blaine EH. Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency. Am J Physiol. 1996;271(1 Pt 2):R200\u2013R207.","journal-title":"Am J Physiol"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.106.086322"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00256.2010"},{"key":"e_1_3_4_6_2","first-page":"H555","article-title":"Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension.","volume":"300","author":"Xue B","year":"2010","unstructured":"Xue B, Beltz TG, Yu Y, Guo F, Gomez-Sanchez CE, Hay M, Johnson AK. Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension. Am J Physiol. 2010; 300: H555\u2013H564.","journal-title":"Am J Physiol"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2011.04.019"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.2011.059840"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00338.2004"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(92)91638-U"},{"key":"e_1_3_4_11_2","article-title":"Central angiotensin II increases circulating endogenous ouabain, arterial myocytes Na\/Ca exchanger expression and blood pressure via brain aldosterone and mineralocorticoid receptors.","author":"Hamlyn JM","year":"2012","unstructured":"Hamlyn JM, Leenen FHH, Golovina VA, Linde CI, Gao J, Huang BS, Ahmad M, Chen L, Li M, Blaustein MP. Central angiotensin II increases circulating endogenous ouabain, arterial myocytes Na\/Ca exchanger expression and blood pressure via brain aldosterone and mineralocorticoid receptors. High Blood Pressure Research 2012 Scientific Sessions. September 19\u201322, 2012. Abstract #419.","journal-title":"High Blood Pressure Research 2012 Scientific Sessions"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.111.185116"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.107.099796"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.90399.2008"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/hy0202.102815"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2010.103"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1966.tb09873.x"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.90352.2008"},{"issue":"1","key":"e_1_3_4_19_2","first-page":"H275","article-title":"Sympathoexcitatory and pressor responses to increased brain sodium and ouabain are mediated via brain ANG II.","volume":"270","author":"Huang BS","year":"1996","unstructured":"Huang BS, Leenen FH. Sympathoexcitatory and pressor responses to increased brain sodium and ouabain are mediated via brain ANG II. Am J Physiol. 1996;270(1 Pt 2):H275\u2013H280.","journal-title":"Am J Physiol"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(94)00266-4"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(96)01381-9"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2011.220"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00063.2005"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2006.04326.x"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2012.224"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000123092"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.7.1.65"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2005.04212.x"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1009898107964"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000256955.74461.93"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.109.140087"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)00078-N"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(96)00167-1"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.167148"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000224296.96235.dd"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.113.01557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:47:53Z","timestamp":1715579273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.113.01557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.113.01557"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.113.01557","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718036765.793482002","asserted-by":"object"}]},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"2013-04-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-06-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-07-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}